| NITI CAR27 (ColonRing) Compression Anastomosis in Colorectal Surgery (NCT01056913) | St John of God Hospital, Vienna | 2008-10-01 |
| Diverting Loop Ileostomy: With or Without Rod (NCT00959738) | Insel Gruppe AG, University Hospital Bern | 2008-08-01 |
| First-Line Bevacizumab and Chemotherapy in Metastatic Cancer of the Colon or Rectum - International Study (NCT00537901) | King Faisal Specialist Hospital & Research Center | 2007-10-01 |
| Concentration of Ertapenem in Colorectal Tissue (NCT00535652) | University of Ulm | 2007-09-01 |
| Pilot Trial of Pre-operative Chemo/RT Using Xeloda and External Beam RT Followed by Definite Surgery in Patients With Localized Rectal CA (NCT00535041) | King Faisal Specialist Hospital & Research Center | 2007-09-01 |
| Local Excision in Downstaged Rectal Cancer (NCT00427375) | University Hospital, Bordeaux | 2007-03-05 |
| XELOX+Bevacizumab Followed by Capecitabine+Bevacizumab+Radiotherapy as Neoadjuvant Treatment of Locally Advanced Rectal Adenocarcinoma (NCT00557713) | Associacio catalana per a la recerca oncologica i les seves implicacions sanitaries i socials | 2007-02-01 |
| The Role of Biofeedback in Improving Continence After Anterior Resection (NCT00515853) | University of Southampton | 2006-11-27 |
| Neoadjuvant Chemoradiotherapy and Adjuvant Chemotherapy With 5-Fluorouracil and Oxaliplatin Versus 5-Fluorouracil Alone in Rectal Cancer (NCT00349076) | University of Erlangen-Nürnberg Medical School | 2006-07-01 |
| A Study of Pemetrexed and Folic Acid Given Before Surgery (Neoadjuvant Treatment) to Patients With Rectal Cancer. (NCT00330915) | Eli Lilly and Company | 2006-06-01 |
| Preoperative Chemoradiotherapy With Cetuximab in Rectal Cancer (NCT00506844) | National Cancer Center, Korea | 2006-05-01 |
| Study of Neoadjuvant Chemotherapeutic Treatment (XELOX) Followed by Chemoradiotherapy (XELOX/RT) and Surgery Versus Chemoradiotherapy Followed by Surgery and Chemotherapy in Patients With High Risk Rectal Cancer (NCT00421824) | Sanofi | 2006-05-01 |
| Genetic Profile on Predicting Sensibility of Preoperative Chemoradiotherapy on Locally Advanced Rectal Carcinoma (NCT01930942) | Chinese Academy of Medical Sciences | 2006-01-01 |
| Endoscopic Posterior Mesorectal Resection in T1 Rectal Cancer (NCT00531297) | Cantonal Hospital of St. Gallen | 2005-12-01 |
| Predictive Factors of Disease-free Survival After Complete Pathological Response to Neoadjuvant Radiotherapy in Rectal Adenocarcinoma (NCT03601689) | Moroccan Society of Surgery | 2005-01-01 |
| Concurrent Chemoradiation With Concomitant Boost In Locally Advanced Rectal Cancer (NCT02723253) | IRCCS Azienda Ospedaliero-Universitaria di Bologna | 2005-01-01 |
| CORE: Capecitabine, Oxaliplatin, Radiotherapy and Excision (NCT00174616) | Sanofi | 2003-07-01 |
| Mesorectal Excision (ME) Versus ME With Lateral Node Dissection for Stage II, III Lower Rectal Cancer (JCOG0212) (NCT00190541) | Haruhiko Fukuda | 2003-06-01 |
| Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Metastatic Colorectal Cancer. (NCT00056459) | Novartis | 2003-02-01 |
| Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Previously Treated Metastatic Colorectal Cancer (NCT00056446) | Novartis Pharmaceuticals | 2003-01-01 |
| Oxaliplatin in Rectal Cancer (NCT00259363) | Sanofi | 2002-10-01 |
| Preoperative Radiotherapy/ Oxaliplatin/ Capecitabine Treatment For Unresectable Locally-advanced Rectal Cancer (NCT00263029) | Sanofi | 2002-06-01 |
| Study of the Efficacy and Safety of Epoetin Alfa Administered Weekly in Patients With Gastric or Rectal Cancers Undergoing a Treatment Plan of Preoperative Chemotherapy and Radiation Therapy, Followed by Surgery (NCT00036400) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2001-12-01 |
| A Phase I Study of Oral Topotecan as a Radiosensitizing Agent in Patients With Rectal Carcinoma (NCT00215956) | H. Lee Moffitt Cancer Center and Research Institute | 2001-11-01 |
| Evaluation of the Neoadjuvant Treatment With Oxaliplatin -UFT- Radiotherapy in Rectal Cancer (NCT00403624) | Sanofi | 2001-07-01 |
| Preoperative Combined Radiation and Chemotherapy - Rectal Cancer (NCT00232453) | University Health Network, Toronto | 2001-03-01 |
| Study Evaluating EKB-569 in Advanced Colorectal Cancer (NCT00072748) | Wyeth is now a wholly owned subsidiary of Pfizer | |
| Study Evaluating MAC-321 in Colorectal Cancer (NCT00063427) | Wyeth is now a wholly owned subsidiary of Pfizer | |